flow trial semaglutide kidney outcomes nejm 2024 hazard ratio Effects of on Chronic Disease in Patients with Type 2 Diabetes The Effects of Semaglutide on
Description
For the weight loss market, Wegovy remains the key competitor to Eli Lilly
doi: 10.1056/NEJMp1314078
Oral semaglutide (Rybelsus) is FDA-approved for type 2 diabetes management only, not for weight management
Help me so much by making me feel healthier
doi: 10.1002/osp4.84 [DOI] [PMC free article] [PubMed] [Google Scholar] 210
